Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

No strong proof that platelet-rich plasma effectively treats hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Hair analysis can offer clues about a person, but individual differences limit making precise identifications.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

A patient with Birt-Hogg-Dubé Syndrome also had choroidal melanoma, suggesting the need for careful eyelid exams in such patients.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Most spinal cord injury patients in Korea experience skin problems, especially fungal infections and eczema, affecting their quality of life.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Older adults in Ottawa commonly have skin conditions like sun damage, dry skin, and hair loss.

6-Gingerol, found in ginger, may slow down hair growth and could be used for hair removal.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Men with shaved heads are seen as more dominant but older and less attractive.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Independent pharmacies generally offer lower prices for certain generic urologic medications than chain pharmacies.

Finasteride treats hair loss but may affect prostate cancer detection.